Japan Diabetes Market Report and Forecast 2015-2020

Imarc

Consulting Services

www.imarcgroup.com

Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

Copyright Š 2015 International Market Analysis Research & Consulting (IMARC). All Rights Reserved

Imarc

About IMARC Group

Report Description

www.imarcgroup.com

The International Market Analysis Research and Consulting Group is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations.

Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Imarc

Report Description and Highlights

Report Description

www.imarcgroup.com

Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics IMARC’s new report “Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Japanese diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Japan. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Japanese diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Japanese diabetes market in any form.

What we have achieved in this report: Comprehensive situation analysis of the Japanese diabetes epidemiology and its dynamics: Focus of the Analysis:

• • • • • • •

Historical, current and future prevalence of diabetes in Japan Historical, current and future prevalence of type-1 and type-2 diabetes in Japan Historical, current and future prevalence of diabetes in the urban and rural regions in Japan Historical, current and future prevalence of diabetes among males and females in Japan Historical, current and future prevalence of diabetes among various age groups in Japan Historical, current and future diagnosis rates for diabetes in Japan Historical, current and future drug treatment rates for diabetes in Japan

Imarc

Report Description and Highlights

Report Description

www.imarcgroup.com

Comprehensive situation analysis of the Japanese Oral Antidiabetics market and its dynamics:

Focus of the Analysis: • • • •

Performance of the Oral Antidiabetics market in Japan Performance of key classes Performance of key players Market outlook

Comprehensive situation analysis of the Japanese Insulin market and its dynamics: Focus of the Analysis: • • • •

Performance of the Insulin market in Japan Performance of key classes Performance of key players Market outlook

Comprehensive situation analysis of the Japanese diabetes diagnostics market and its dynamics: Focus of the Analysis: • • • •

Performance of the diabetes diagnostics market in Japan Market Segmentation Key players Market outlook

Imarc www.imarcgroup.com

Japan Diabetes Market

Imarc

Report Description and Highlights

Report Description

www.imarcgroup.com

Table of Contents 1 Research Methodology 2 Executive Summary 3 Diabetes Disease Overview 3.1 What is Diabetes?

3.2 Diabetes Diagnosis and Treatment 3.2.1 Diagnosis 3.2.2 Treatment 3.3 Diabetes Complications 4 Key Factors Driving the Diabetes Market in Japan 5 Japan Diabetes Epidemiology 5.1 Diabetes Population and Prevalence Rates 5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2) 5.3 Population and Prevalence Rates by Region 5.4 Population and Prevalence Rates by Gender 5.5 Population and Prevalence Rates by Age Group 5.6 Diabetes Diagnosis and Drug Treatment Rates 6 Japan Diabetes Market 6.1 Historical Market Trends (2007-2014) 6.2 Market Breakup by Segment (2007-2014) 6.3 Japan Oral Antidiabetics Market 6.3.1 Historical Market Trends (2007-2014) 6.3.2 Market Breakup by Class (2007-2014)

Imarc

Report Description and Highlights

Report Description

www.imarcgroup.com

6.3.3 Market Shares of Key Players 6.3.4 Market Outlook (2015-2020) 6.4 Japan Insulin Market 6.4.1 Historical Market Trends (2015-2020) 6.4.2 Market Breakup by Class 6.4.3 Market Shares of Key Players 6.4.4 Market Outlook (2015-2020) 6.5 Market Outlook (2015-2020) 7 Japan Diabetes Diagnostics Market 7.1 Historical Market Trends (2007-2014) 7.2 Market Segmentation 7.3 Key Players 7.4 Market Outlook (2015-2020) List of Figures

Figure 3 1: The Impact of Diabetes on the Human Body Figure 3 2: Diabetes Complications Figure 4 1: Japan: Overweight & Obese Population (in Millions), 2007, 2014 & 2020 Figure 4 2: Body Mass Index and Relative Risk of Type-2 Diabetes Figure 4 3: Global: Breakup of Diabetes Patients by Region (in %), 2014 & 2030 Figure 5 1: Japan: Total Number of Diabetes Patients (in Millions), 2007- 2014 Figure 5 2: Japan: Total Number of Diabetes Patients (in Millions), 2015 – 2020 Figure 5 3: Japan (Type1 & Type2): Total Number of Diabetes Patients (in Millions), 2007- 2014

Imarc

Report Description and Highlights

Report Description

www.imarcgroup.com

Figure 5 4: Japan (Type1 & Type2): Total Number of Diabetes Patients (in Millions), 2015 – 2020 Figure 5 5: Japan (Urban & Rural): Total Number of Diabetes Patients (in Millions), 2007- 2014 Figure 5 6: Japan (Urban & Rural): Total Number of Diabetes Patients (in Millions), 2015 – 2020 Figure 5 7: Japan (Male & Female): Total Number of Diabetes Patients (in Millions), 2007- 2014 Figure 5 8: Japan (Male & Female): Total Number of Diabetes Patients (in Millions), 2015 – 2020 Figure 5 9: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in Millions), 20072014 Figure 5 10: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in Millions), 2015 – 2020 Figure 5 11: Japan: Total Diagnosed & Drug Treated Diabetes Population (in Millions), 2007- 2014 Figure 5 12: Japan: Total Diagnosed & Drug Treated Diabetes Population (in Millions), 2015 – 2020 Figure 6 1: Japan: Diabetes Market (in Million US$), 2007-2014 Figure 6 2: Japan: Diabetes Market: Share of Oral Antidiabetics and Insulin (in %), 2007-2014 Figure 6 3: Japan: Oral Antidiabetics Market (in Million US$), 2007-2014 Figure 6 4: Japan: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2007-2014 Figure 6 5: Japan: Oral Antidiabetics Market: Sales Share of Key Players (in %) Figure 6 6: Japan: Oral Antidiabetics Market Forecast (in Million US$), 2015-2020 Figure 6 7: Japan: Oral Antidiabetics Market Forecast: Sales Share of Key Classes (in %), 2015 & 2020 Figure 6 8: Japan: Insulin Market (in Million US$), 2007-2014 Figure 6 9: Japan: Insulin Market: Sales Share of Key Classes (in %), 2014 Figure 6 10: Japan: Insulin Market: Sales Share of Key Players (in %) Figure 6 11: Japan: Insulin Market Forecast (in Million US$), 2015-2020 Figure 6 12: Japan: Insulin Market Forecast: Sales Share of Key Classes (in %), 2015 & 2020 Figure 6 13: Japan: Diabetes Market Forecast (in Million US$), 2015-2020

Imarc

Report Description and Highlights

Report Description

www.imarcgroup.com

Figure 6 14: Japan: Diabetes Market Forecast: Share of Oral Antidiabetics and Insulin (in %), 2015-2020 Figure 7 1: Japan: Diabetes Diagnostics Market (in Million US$), 2007-2014 Figure 7 2: Japan: Diabetes Diagnostics Market Forecast (in Million US$), 2015-2020 List of Tables Table 2 1: Japan: Diabetes Epidemiology: Executive Summary Table 2 2: Japan: Diabetes Market: Executive Summary Table 3 1: Diagnosis of Diabetes Table 4 1: Japan: Overweight & Obesity Statistics, 2006, 2010 & 2014 Table 4 2: Japan: Urban & Rural Population Breakup (in Millions), 1991, 2001, 2011 & 2014 Table 4 3: Global: Diabetes Population Breakup by Country (in 000’s), 2014 & 2020 Table 4 4: Global: Market Size & Growth Rates of Top Emerging and Developed Diabetes Drug Markets Table 5 1: Japan: Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020 Table 5 2: Japan (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020 Table 5 3: Japan (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020 Table 5 4: Japan (Male & Female): Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020 Table 5 5: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2007, 2014 & 2020 Table 5 6: Japan: Total Diagnosed & Drug Treated Diabetes Population, 2007, 2014 & 2020

Imarc

Report Description and Highlights

Report Description

www.imarcgroup.com

To buy the complete report or to get a free sample, please contact:

IMARC Group Asia: Email: apac@imarcgroup.com Phone: +91-120-415-5099

IMARC Group North America: Email: america@imarcgroup.com Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa: Email:ema@imarcgroup.com Phone: +44-702-409-7331

To know more please visit: http://www.imarcgroup.com/japan-diabetes-market

Imarc

Report Description and Highlights

Report Description

www.imarcgroup.com

Š 2015 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing.

International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

Contact Us

FOR MORE DETAILS Visit us at :

http://www.imarcgroup.com Stay With Us:

TELEPHONE: +91-120-4155099 E-MAIL: sales@imarcgroup.com